Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Incannex Healthcare (IXHL) Shares Outstanding (Weighted Average) (2020 - 2025)

Incannex Healthcare's Shares Outstanding (Weighted Average) history spans 4 years, with the latest figure at $330.0 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 1772.31% to $330.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $330.0 million, a 1772.31% increase, with the full-year FY2025 number at $34.5 million, up 113.15% from a year prior.
  • Shares Outstanding (Weighted Average) hit $330.0 million in Q4 2025 for Incannex Healthcare, up from $310.3 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for IXHL hit a ceiling of $330.0 million in Q4 2025 and a floor of $15.4 million in Q2 2023.
  • Historically, Shares Outstanding (Weighted Average) has averaged $73.5 million across 3 years, with a median of $17.6 million in 2024.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): rose 5.07% in 2024 and later skyrocketed 1772.31% in 2025.
  • Tracing IXHL's Shares Outstanding (Weighted Average) over 3 years: stood at $15.9 million in 2023, then grew by 11.03% to $17.6 million in 2024, then skyrocketed by 1772.31% to $330.0 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for IXHL at $330.0 million in Q4 2025, $310.3 million in Q3 2025, and $34.5 million in Q2 2025.